1598733: ROMIPLOSTIN FOR INJECTION.
The ROMIPLOSTIN FOR INJECTION is a the manufacturer industrial component. Key specifications include administration: SUBCUTANEOUS, primary_container_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, primary_container_content_quantity: 500.0 MICROGRAMS OF ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: ROMIPLOSTIM, NPLATE, 500MCG SDV 1ML VIAL. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-697-1709, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | SUBCUTANEOUS |
| special_features | 500MCG SDV; 1 ML VIAL. NPLATE ROMIPLOSTIM IS A THROMBOPOIETIN RECEPTOR AGONIST INDICATED FOR THE TREATMENT OF THROMBOCYTOPENIA. STORE AT 2 TO 8C. PROTECT FROM LIGHT. DO NOT FREEZE. |
| primary_container_type | VIAL |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 500.0 MICROGRAMS OF ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | ROMIPLOSTIM, NPLATE, 500MCG SDV 1ML VIAL |
| NSN | 6505-01-697-1709 |
| ADMINISTRATION | SUBCUTANEOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.0 MICROGRAMS OF ACTIVE INGREDIENT |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | 500MCG SDV; 1 ML VIAL. NPLATE ROMIPLOSTIM IS A THROMBOPOIETIN RECEPTOR AGONIST INDICATED FOR THE TREATMENT OF THROMBOCYTOPENIA. STORE AT 2 TO 8C. PROTECT FROM LIGHT. DO NOT FREEZE. |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ROMIPLOSTIM, NPLATE, 500MCG SDV 1ML VIAL |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |